m-azidopyrimethamine
Term · Oncology and biomedicine · MLC-T-ONC-015029
An antifolate derived from diaminopyrimidine with cytotoxic properties. With a mechanism of action similar to that of methotrexate (MTX), m-azidopyrimethamine blocks tetrahydrofolate synthesis, resulting in depletion of nucleotide precursors and inhibition of DNA, RNA and protein synthesis. This agent is more lipophilic but less potent than MTX.
| Identifier | MLC-T-ONC-015029 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | MZP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015029",
"term": "m-azidopyrimethamine",
"field": "Oncology and biomedicine",
"definition": "An antifolate derived from diaminopyrimidine with cytotoxic properties. With a mechanism of action similar to that of methotrexate (MTX), m-azidopyrimethamine blocks tetrahydrofolate synthesis, resulting in depletion of nucleotide precursors and inhibition of DNA, RNA and protein synthesis. This agent is more lipophilic but less potent than MTX.",
"abbreviation": "MZP",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/m-azidopyrimethamine/"
}
Record 10,687 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.